Propanc Biopharma Stock Price on August 15, 2024
| PPCB Stock | USD 0.0003 0.0001 25.00% |
If you're considering investing in Propanc Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Propanc Biopharma stands at 0.0003, as last reported on the 22nd of November, with the highest price reaching 0.0003 and the lowest price hitting 0.0003 during the day. Propanc Biopharma appears to be out of control, given 3 months investment horizon. Propanc Biopharma maintains Sharpe Ratio (i.e., Efficiency) of 0.0437, which implies the firm had a 0.0437% return per unit of risk over the last 3 months. By analyzing Propanc Biopharma's technical indicators, you can evaluate if the expected return of 0.66% is justified by implied risk. Please evaluate Propanc Biopharma's Coefficient Of Variation of 4564.65, semi deviation of 10.58, and Risk Adjusted Performance of 0.0262 to confirm if our risk estimates are consistent with your expectations.
Propanc Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Propanc |
Sharpe Ratio = 0.0437
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PPCB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 15.12 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.66 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Propanc Biopharma is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Propanc Biopharma by adding it to a well-diversified portfolio.
Related Headline
Tempest Therapeutics Headline on 15th of August 2024
Tempest Announces Successful End-of-Phase 2 Meeting with FDA... by finance.yahoo.com
Broad agreement on pivotal Phase 3 study plan, including use of current amezalpat dose and scheduleOverall survival, the strongest result from the Phase 2 trial, will be the primary study endpointAgreed-upon early efficacy analysis could reduce time to primary read-out significantly BRISBANE, Calif., Aug. 15, 2024 -- Tempest Therapeutics, Inc. , a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight canc
Propanc Biopharma Valuation on August 15, 2024
It is possible to determine the worth of Propanc Biopharma on a given historical date. On August 15, 2024 Propanc was worth 5.0E-4 at the beginning of the trading date compared to the closed value of 4.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Propanc Biopharma pink sheet. Still, in general, we apply an absolute valuation method to find Propanc Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Propanc Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Propanc Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.0004 | 0.0006 | 0.0004 | 0.0006 | 35,776,646 | |
08/15/2024 | 0.0005 | 0.0005 | 0.0004 | 0.0004 | 21,385,000 |
| 0.0005 | 0.0005 | 0.0004 | 0.0005 | 14,391,551 |
| Backtest Propanc Biopharma | | | Propanc Biopharma History | | | Propanc Biopharma Valuation | Previous | Next |
Propanc Biopharma Trading Date Momentum on August 15, 2024
| On August 16 2024 Propanc Biopharma was traded for 0.0005 at the closing time. The top price for the day was 0.0005 and the lowest listed price was 0.0004 . The trading volume for the day was 14.4 M. The trading history from August 16, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 25.00% . The trading delta at closing time against the current closing price is 25.00% . |
Propanc Biopharma Fundamentals Correlations and Trends
By evaluating Propanc Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Propanc Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Propanc financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Propanc Biopharma Pink Sheet history
Propanc Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Propanc is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Propanc Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Propanc Biopharma stock prices may prove useful in developing a viable investing in Propanc Biopharma
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia. Propanc Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
Propanc Biopharma Pink Sheet Technical Analysis
Propanc Biopharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Propanc Biopharma Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Propanc Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Propanc Biopharma November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Propanc Biopharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Propanc Biopharma shares will generate the highest return on investment. By undertsting and applying Propanc Biopharma pink sheet market strength indicators, traders can identify Propanc Biopharma entry and exit signals to maximize returns
Propanc Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Propanc Biopharma's price direction in advance. Along with the technical and fundamental analysis of Propanc Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Propanc to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0262 | |||
| Jensen Alpha | 0.0387 | |||
| Total Risk Alpha | (1.64) | |||
| Sortino Ratio | 0.0083 | |||
| Treynor Ratio | 0.1133 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Propanc Pink Sheet analysis
When running Propanc Biopharma's price analysis, check to measure Propanc Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Propanc Biopharma is operating at the current time. Most of Propanc Biopharma's value examination focuses on studying past and present price action to predict the probability of Propanc Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Propanc Biopharma's price. Additionally, you may evaluate how the addition of Propanc Biopharma to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |